RE:Soooo when is it our turn?Not sure Medipharms and Valens would be considered competitors in the extraction space, both had exited or drastically reduced their services in that regard long ago. Remember when Adastra/Phyto Extractions was on the scene for a cup of coffee? Now they sell pre-rolls.
Not unrelated though, the demise of Valens and Medipharms extraction divisions was likely the proverbial pee in the pool that chased many investors away from the space as a viable industry. This larger step into the commercial CBD space should bring new attention to this model (if successful).
Rat1Race wrote: We all know of the Valens purchase from earlier this week but old news along with it was the analyst downgrade of Medipharm as well a week ago. See below.
Looks like we're running out of compeition in the space. Hopefully that helps us stand out and brings with itr some inbound leads to the sales and marketing teams fopr more bulk orders.
https://finance.yahoo.com/news/analysts-just-made-major-revision-101201815.html